Trade Akso Health Group - AHG CFD
Add to favourite- Summary
- Historical Data
- Events
- Income Statement
- Balance Sheet
- Cash Flow
- Ownership
Spread | 0.122 | ||||||||
Long position overnight fee
Long position overnight fee
Go to platform | -0.026179% | ||||||||
Short position overnight fee
Short position overnight fee
Go to platform | 0.003957% | ||||||||
Overnight fee time | 22:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | USD | ||||||||
Margin | 5% | ||||||||
Stock exchange | United States of America | ||||||||
Commission on trade | 0% |
*Information provided by Capital.com
Prev. Close* | 0.995 |
Open* | 0.999 |
1-Year Change* | 189.57% |
Day's Range* | 0.999 - 1.349 |
52 wk Range | 0.25-2.11 |
Average Volume (10 days) | 203.43K |
Average Volume (3 months) | 2.53M |
Market Cap | 50.45M |
P/E Ratio | -100.00K |
Shares Outstanding | 68.60M |
Revenue | 2.20M |
EPS | -0.75 |
Dividend (Yield %) | N/A |
Beta | 0.00 |
Next Earnings Date | N/A |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Mar 18, 2024 | 1.229 | 0.231 | 23.15% | 0.998 | 1.349 | 0.998 |
Mar 15, 2024 | 0.995 | -0.244 | -19.69% | 1.239 | 1.299 | 0.969 |
Mar 14, 2024 | 1.249 | 0.060 | 5.05% | 1.189 | 1.369 | 1.169 |
Mar 13, 2024 | 1.219 | -0.050 | -3.94% | 1.269 | 1.369 | 1.219 |
Mar 12, 2024 | 1.329 | 0.120 | 9.93% | 1.209 | 1.519 | 1.209 |
Mar 11, 2024 | 1.259 | -0.040 | -3.08% | 1.299 | 1.309 | 1.229 |
Mar 8, 2024 | 1.199 | -0.070 | -5.52% | 1.269 | 1.269 | 1.199 |
Mar 7, 2024 | 1.299 | 0.080 | 6.56% | 1.219 | 1.379 | 1.199 |
Mar 6, 2024 | 1.259 | 0.050 | 4.14% | 1.209 | 1.439 | 1.169 |
Mar 5, 2024 | 1.159 | -0.050 | -4.14% | 1.209 | 1.309 | 1.159 |
Mar 4, 2024 | 1.199 | -0.130 | -9.78% | 1.329 | 1.379 | 1.199 |
Mar 1, 2024 | 1.329 | 0.050 | 3.91% | 1.279 | 1.379 | 1.219 |
Feb 29, 2024 | 1.289 | 0.000 | 0.00% | 1.289 | 1.309 | 1.249 |
Feb 28, 2024 | 1.209 | -0.040 | -3.20% | 1.249 | 1.299 | 1.179 |
Feb 27, 2024 | 1.309 | -0.020 | -1.50% | 1.329 | 1.469 | 1.189 |
Feb 26, 2024 | 1.359 | 0.130 | 10.58% | 1.229 | 1.449 | 1.109 |
Feb 23, 2024 | 1.269 | 0.210 | 19.83% | 1.059 | 1.319 | 1.059 |
Feb 22, 2024 | 1.129 | 0.060 | 5.61% | 1.069 | 1.179 | 1.069 |
Feb 21, 2024 | 1.129 | -0.130 | -10.33% | 1.259 | 1.299 | 1.129 |
Feb 20, 2024 | 1.229 | -0.140 | -10.23% | 1.369 | 1.369 | 1.229 |
Akso Health Group Events
Time (UTC) | Country | Event |
---|---|---|
No events scheduled |
- Annual
- Quarterly
2023 | 2022 | 2021 | 2020 | 2019 | |
---|---|---|---|---|---|
Total revenue | 13.1816 | 6 | 0 | 6.91447 | 3.69522 |
Revenue | 13.1816 | 6 | 0 | 6.91447 | 3.69522 |
Total Operating Expense | 27.4484 | 9.26046 | 4.24125 | 55.0202 | 10.8844 |
Selling/General/Admin. Expenses, Total | 15.5358 | 3.06146 | 2.08663 | 22.2991 | 10.8844 |
Research & Development | 1.03256 | 0 | |||
Operating Income | -14.2669 | -3.26046 | -4.24125 | -48.1057 | -7.18919 |
Other, Net | 1.20036 | -0.74782 | -0.05208 | 1.23216 | 0.38115 |
Net Income Before Taxes | -13.0665 | -4.00828 | -4.29333 | -46.8735 | -6.80804 |
Net Income After Taxes | -13.084 | -4.1011 | -4.29333 | -47.3635 | -7.61575 |
Net Income Before Extra. Items | -13.1965 | -4.10243 | -4.29333 | -47.3635 | -7.61575 |
Net Income | -1.35992 | -16.8511 | -34.827 | -71.1984 | 5.53258 |
Income Available to Common Excl. Extra. Items | -13.1965 | -4.10243 | -4.29333 | -47.3635 | -7.61575 |
Income Available to Common Incl. Extra. Items | -1.35992 | -16.8511 | -34.827 | -71.1984 | 5.53258 |
Dilution Adjustment | |||||
Diluted Net Income | -1.35992 | -16.8511 | -34.827 | -71.1984 | 5.53258 |
Diluted Weighted Average Shares | 68.5981 | 59.6121 | 48.838 | 48.7572 | 48.6932 |
Diluted EPS Excluding Extraordinary Items | -0.19237 | -0.06882 | -0.08791 | -0.97142 | -0.1564 |
Diluted Normalized EPS | -0.19237 | -0.06882 | -0.08791 | -0.58227 | -0.1564 |
Minority Interest | -0.1125 | -0.00133 | |||
Interest Expense (Income) - Net Operating | 0 | 0.80414 | 2.15462 | 2.49871 | 0 |
Unusual Expense (Income) | 29.1898 | 0 | |||
Total Extraordinary Items | 11.8366 | -12.7486 | -30.5337 | -23.8349 | 13.1483 |
Cost of Revenue, Total | 11.9126 | 5.39487 | 0 | ||
Gross Profit | 1.26899 | 0.60513 | 0 |
Mar 2023 | Sep 2022 | Mar 2022 | Sep 2021 | Mar 2021 | |
---|---|---|---|---|---|
Total revenue | 1.30914 | 11.8724 | 5.75408 | 0.24592 | 0 |
Revenue | 1.30914 | 11.8724 | 5.75408 | 0.24592 | 0 |
Total Operating Expense | 14.5258 | 12.9226 | 0.54471 | 8.71575 | 4.24125 |
Selling/General/Admin. Expenses, Total | 13.3444 | 2.10033 | 0.22 | 2.84146 | 2.08663 |
Research & Development | 0.09108 | -0.24023 | 0.24023 | ||
Interest Expense (Income) - Net Operating | 0 | 0 | 0.20414 | 0.6 | 2.15462 |
Other Operating Expenses, Total | -5.03406 | 5.03406 | |||
Operating Income | -13.2167 | -1.05019 | 5.20937 | -8.46983 | -4.24125 |
Other, Net | -0.68801 | 1.88837 | -0.31943 | -0.42838 | -0.05208 |
Net Income Before Taxes | -13.9047 | 0.83818 | 4.88993 | -8.89821 | -4.29333 |
Net Income After Taxes | -13.9105 | 0.82644 | 4.81502 | -8.91611 | -4.29333 |
Net Income Before Extra. Items | -14.0069 | 0.81034 | 4.81369 | -8.91611 | -4.29333 |
Net Income | -2.17026 | 0.81034 | -7.93495 | -8.91611 | -34.827 |
Income Available to Common Excl. Extra. Items | -14.0069 | 0.81034 | 4.81369 | -8.91611 | -4.29333 |
Income Available to Common Incl. Extra. Items | -2.17026 | 0.81034 | -7.93495 | -8.91611 | -34.827 |
Diluted Net Income | -2.17026 | 0.81034 | -7.93495 | -8.91611 | -34.827 |
Diluted Weighted Average Shares | 68.5981 | 68.5981 | 68.549 | 50.6754 | 48.838 |
Diluted EPS Excluding Extraordinary Items | -0.20419 | 0.01181 | 0.07022 | -0.17595 | -0.08791 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | |||
Diluted Normalized EPS | -0.20419 | 0.01181 | 0.07022 | -0.17595 | -0.08791 |
Unusual Expense (Income) | |||||
Total Extraordinary Items | 11.8366 | -12.7486 | 0 | -30.5337 | |
Cost of Revenue, Total | 1.18137 | 10.7312 | 5.39487 | ||
Gross Profit | 0.12777 | 1.14122 | 0.35921 | ||
Minority Interest | -0.0964 | -0.0161 | -0.00133 | ||
Total Adjustments to Net Income | 0 | 0 |
- Annual
- Quarterly
2023 | 2022 | 2021 | 2020 | 2019 | |
---|---|---|---|---|---|
Total Current Assets | 20.4603 | 62.8065 | 30.1225 | 52.0182 | 97.6806 |
Cash and Short Term Investments | 7.92447 | 18.43 | 15.1287 | 6.6681 | 57.3721 |
Cash & Equivalents | 7.92447 | 18.43 | 15.1287 | 6.6681 | 57.3721 |
Total Receivables, Net | 9.2259 | 20 | 14.401 | 36.2627 | 36.9735 |
Prepaid Expenses | 0.27213 | 0.17698 | 0.59278 | 0.40082 | 3.33497 |
Total Assets | 20.4603 | 62.8065 | 31.6855 | 80.4762 | 173.256 |
Property/Plant/Equipment, Total - Net | 0.06689 | 0.76357 | 1.25372 | ||
Note Receivable - Long Term | 1.49612 | 22.3081 | 39.8105 | ||
Other Long Term Assets, Total | 3.78633 | 3.72118 | |||
Total Current Liabilities | 11.6208 | 50.5209 | 14.414 | 12.3618 | 26.5627 |
Accrued Expenses | 0.93877 | 0.22588 | 1.14251 | 1.89035 | 2.7911 |
Notes Payable/Short Term Debt | 9.68615 | 37.2 | 2.96878 | 2.09368 | 0 |
Other Current Liabilities, Total | 0.99586 | 13.095 | 0.30268 | 8.37774 | 23.7716 |
Total Liabilities | 11.735 | 50.5229 | 14.414 | 32.3753 | 46.7527 |
Total Long Term Debt | 0 | 0 | 0 | 20 | 20 |
Total Equity | 8.7253 | 12.2836 | 17.2715 | 48.1009 | 126.503 |
Common Stock | 0.00698 | 0.00698 | 0.005 | 0.005 | 0.00496 |
Additional Paid-In Capital | 71.0219 | 71.0219 | 60.6151 | 60.5596 | 59.8069 |
Retained Earnings (Accumulated Deficit) | -54.4676 | -53.1077 | -36.2566 | -1.42962 | 69.7688 |
Other Equity, Total | -3.8476 | -1.64922 | -3.10354 | -7.0457 | -1.75696 |
Total Liabilities & Shareholders’ Equity | 20.4603 | 62.8065 | 31.6855 | 80.4762 | 173.256 |
Total Common Shares Outstanding | 49.2041 | ||||
Accounts Receivable - Trade, Net | 7.69698 | 0 | 0.02836 | 0.00188 | 0.41864 |
Property/Plant/Equipment, Total - Gross | 0.13197 | 0.80927 | 1.99927 | ||
Accumulated Depreciation, Total | -0.06508 | -0.0457 | -0.74555 | ||
Long Term Investments | 0 | 1.6 | 30.7898 | ||
Long Term Debt | 0 | 20 | 20 | ||
Other Liabilities, Total | 0 | 0.0135 | 0.18996 | ||
Treasury Stock - Common | -3.98837 | -3.98837 | -3.98837 | -3.98837 | -1.32047 |
Other Current Assets, Total | 1.35135 | 16.4037 | 0 | 8.68651 | |
Current Port. of LT Debt/Capital Leases | 10 | 0 | |||
Total Inventory | 1.68645 | 7.79582 | |||
Minority Interest | 0.11421 | 0.00198 |
Mar 2023 | Sep 2022 | Mar 2022 | Sep 2021 | Mar 2021 | |
---|---|---|---|---|---|
Total Current Assets | 20.4603 | 20.871 | 62.8065 | 22.3104 | 30.1225 |
Cash and Short Term Investments | 7.92447 | 9.99056 | 18.43 | 15.4568 | 15.1287 |
Cash & Equivalents | 7.92447 | 9.99056 | 18.43 | 15.4568 | 15.1287 |
Total Receivables, Net | 9.2259 | 7.92858 | 20 | 6.56152 | 14.3892 |
Accounts Receivable - Trade, Net | 7.69698 | 7.92858 | 0 | 0.01776 | 0.02836 |
Prepaid Expenses | 0.27213 | 2.05229 | 0.17698 | 0.29201 | 0.60452 |
Total Assets | 20.4603 | 20.9073 | 62.8065 | 32.5244 | 31.6855 |
Property/Plant/Equipment, Total - Net | 0.03631 | 0.06881 | 0.06689 | ||
Long Term Investments | 0 | ||||
Note Receivable - Long Term | 0 | 1.49612 | |||
Other Long Term Assets, Total | 10.1453 | ||||
Total Current Liabilities | 11.6208 | 10.9772 | 50.5209 | 12.9722 | 14.414 |
Accrued Expenses | 0.93877 | 1.18238 | 0.22588 | 0.945 | 1.14251 |
Notes Payable/Short Term Debt | 9.68615 | 9.68615 | 37.2 | 2 | 2.96878 |
Other Current Liabilities, Total | 0.99586 | 0.10871 | 13.095 | 0.02725 | 0.30268 |
Total Liabilities | 11.735 | 10.9944 | 50.5229 | 12.9722 | 14.414 |
Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
Long Term Debt | 0 | ||||
Other Liabilities, Total | 0 | ||||
Total Equity | 8.7253 | 9.91285 | 12.2836 | 19.5522 | 17.2715 |
Common Stock | 0.00698 | 0.00698 | 0.00698 | 0.00698 | 0.005 |
Additional Paid-In Capital | 71.0219 | 71.0219 | 71.0219 | 71.0219 | 60.6151 |
Retained Earnings (Accumulated Deficit) | -54.4676 | -52.2973 | -53.1077 | -45.1727 | -36.2566 |
Treasury Stock - Common | -3.98837 | -3.98837 | -3.98837 | -3.98837 | -3.98837 |
Other Equity, Total | -3.8476 | -4.83032 | -1.64922 | -2.31557 | -3.10354 |
Total Liabilities & Shareholders’ Equity | 20.4603 | 20.9073 | 62.8065 | 32.5244 | 31.6855 |
Total Common Shares Outstanding | |||||
Other Current Assets, Total | 1.35135 | 16.4037 | 0 | ||
Current Port. of LT Debt/Capital Leases | 10 | 10 | |||
Total Inventory | 1.68645 | 0.89956 | 7.79582 | ||
Minority Interest | 0.11421 | 0.01721 | 0.00198 | ||
Property/Plant/Equipment, Total - Gross | 0.12593 | ||||
Accumulated Depreciation, Total | -0.08962 |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Net income/Starting Line | -16.8497 | -31.5522 | -47.3635 | 5.53258 | 65.5106 |
Cash From Operating Activities | -8.62837 | 10.0585 | -58.2787 | -1.73108 | 87.723 |
Cash From Operating Activities | 0.01839 | 0.01516 | 0.12052 | 0.4068 | 0.17438 |
Deferred Taxes | 0 | 0 | 3.3083 | -3.72408 | 0.41562 |
Changes in Working Capital | -2.56415 | 23.2255 | -32.9 | -11.6206 | 19.7935 |
Cash From Investing Activities | -19.9639 | -0.00066 | 12.7754 | -68.1066 | -27.6238 |
Capital Expenditures | -0.00486 | 0 | -0.20036 | -0.94481 | -0.45603 |
Cash From Financing Activities | 34.7811 | -9.03722 | -1.55219 | -0.02938 | 47.5163 |
Financing Cash Flow Items | 10.0172 | 0.03694 | 7.36367 | -0.318 | 4.24256 |
Issuance (Retirement) of Stock, Net | 0 | 0.00001 | -2.26261 | -0.16385 | 43.2737 |
Foreign Exchange Effects | 0.60772 | 3.18293 | 0.60864 | -5.38333 | 5.77472 |
Net Change in Cash | 6.7966 | 4.20351 | -46.4469 | -75.2503 | 113.39 |
Non-Cash Items | 10.7671 | 18.3701 | 18.556 | 7.67422 | 1.82887 |
Cash Taxes Paid | 0.03862 | 0.00976 | 3.20938 | 12.2482 | 1.01696 |
Other Investing Cash Flow Items, Total | -19.959 | -0.00066 | 12.9757 | -67.1617 | -27.1678 |
Total Cash Dividends Paid | 0 | 0 | -19.5475 | ||
Issuance (Retirement) of Debt, Net | 24.7639 | -9.07416 | -6.65324 | 20 |
Sep 2022 | Mar 2022 | Sep 2021 | Mar 2021 | Sep 2020 | |
---|---|---|---|---|---|
Net income/Starting Line | 0.82644 | ||||
Cash From Operating Activities | -1.33412 | ||||
Cash From Operating Activities | 0.01384 | ||||
Non-Cash Items | 0 | ||||
Changes in Working Capital | -2.17439 | ||||
Cash From Investing Activities | 20 | ||||
Other Investing Cash Flow Items, Total | 20 | ||||
Cash From Financing Activities | -27.5138 | ||||
Financing Cash Flow Items | -27.5138 | ||||
Foreign Exchange Effects | -3.0868 | ||||
Net Change in Cash | -11.9348 |
Investor Name | Investor Type | Percent Outstanding | Shares Held | Shares change | Holdings Date | Turnover Rating |
---|---|---|---|---|---|---|
Renaissance Technologies LLC | Hedge Fund | 0.8998 | 214398 | -19300 | 2023-06-30 | HIGH |
Two Sigma Investments, LP | Hedge Fund | 0.4789 | 114093 | -6920 | 2023-06-30 | HIGH |
Rhumbline Advisers Ltd. Partnership | Investment Advisor | 0.0837 | 19940 | 19940 | 2023-06-30 | LOW |
HRT Financial LP | Investment Advisor | 0.0423 | 10073 | 10073 | 2023-06-30 | HIGH |
Morgan Stanley & Co. LLC | Research Firm | 0.0141 | 3370 | 0 | 2023-06-30 | MED |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Akso Health Group Company profile
About Akso Health Group - ADR
Akso Health Group, formerly Xiaobai Maimai Inc, is a China-based company mainly engaged in e-commerce business. The Company provides services through the Xiaobai Maimai application (APP), a one-stop e-commerce platform. The Company provides products covering food and beverage, wine, cosmetic products, fashion and apparel, entertainment, houseware, home appliances and others.
Financial summary
BRIEF: For the six months ended 30 September 2021, AksoHealth Group - ADR revenues decreased 82% to $246K. Netloss before extraordinary items decreased 49% to $8.9M.Revenues reflect Interest income decrease of 82% to $187K,Commission services decrease of 81% to $60K. Lower net lossreflects Provision for uncollectable loans receiv decreaseof 61% to $5M (expense), General and administrativedecrease of 25% to $2.3M (expense).
Industry: | E-commerce & Auction Services |
Rm 8201-4-4(A) 2Nd Floor Qiantongyua Bld
No. 44 Moscow Rd Qianwan Bonded Port Are
BEIJING
BEIJING 0000
CN
Income Statement
- Annual
- Quarterly
News
Bank of Japan Preview: will the BOJ end negative interest rates?
The Bank of Japan meets on Tuesday 19th of March. We preview what to expect from the BOJ decision and how it might impact the USD/JPY and Nikkei 225.
08:44, 18 March 2024Higher CPI leaves traders unfazed as US equities continue to build momentum
The latest US CPI reading hasn’t gone how the Federal would have hoped. Consumer prices came in higher than expected in February for the third month in a row.
12:42, 15 March 2024Four reasons why Bitcoin is surging to record highs
Bitcoin has surged to record highs. We discuss the four factors pushing Bitcoin higher and analyse the technicals of the cryptocurrency’s technicals.
10:18, 14 March 2024China’s National People’s Congress: The markets have again been left wanting more
China’s National People’s Congress (NPC) is underway, and the markets have so far been disappointed by what’s been delivered by the country’s central government. We look at some of the significant takeaways from the event, discuss China’s current economic conditions, and analyse the China A50.
08:23, 8 March 2024Central Banks: which one will cut first?
Central banks dominate the calendar in March and markets try to anticipate which one will be the first one to cut
13:14, 6 March 2024Nvidia (NVDA) confronts high expectations for Q4 results
Nvidia is arguably the hottest company on the planet. The company reports its Q4 results after the closing bell on Wednesday, the 21st of February. We preview what to expect from Nvidia’s earnings and analyse the technicals of its stock price.
12:13, 20 February 2024UK Bank Earnings: What to expect from Lloyds, Barclays and HSBC?
UK banks will be in the spotlight in the week ahead as the European earnings season continues
16:38, 16 February 2024People also watch
Still looking for a broker you can trust?
Join the 580.000+ traders worldwide that chose to trade with Capital.com